Browsing: Novo
hapabapa/iStock Editorial via Getty Images IMMvention Therapeutix announced a strategic collaboration and license agreement with Novo Nordisk A/S (NVO) to…
aprott/iStock via Getty ImagesNovo Nordisk (NVO) announced Friday that a higher-dose version of its popular obesity therapy, semaglutide, marketed as…
Terminator3D/iStock via Getty ImagesBlockbuster weight loss medications from Novo Nordisk (NVO) and Eli Lilly (NYSE:LLY) lead Evaluate Pharma’s list of…
hapabapa/iStock Editorial via Getty ImagesNovo Nordisk (NOVO) is petitioning the FDA to exclude its diabetes drug liraglutide, also known as…
CRNovo Nordisk (NVO) and Eli Lilly (LLY), the undisputed leaders in the global obesity drug market, saw their stocks heading…
Investing.com — The Danish krone experienced a dip following disappointing clinical trial results from Denmark’s pharmaceutical giant, Novo Nordisk (NYSE:)…
hapabapa/iStock Editorial via Getty ImagesNovo Nordisk’s (NVO) next-gen weight loss therapy, CagriSema, caused up to ~23% of weight loss compared…